Skip to main content

Table 2 Design matrix of hypoxia/cisplatin treatments

From: Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer

Pre-treatment Treatment Day 1 Treatment Day 2 Treatment Day 3
  (0 – 24 h) (24 – 48 h) (48 – 72 h)
Normoxia Normoxia Normoxia Normoxia
Normoxia Hypoxia Hypoxia Hypoxia
Normoxia Normoxia Hypoxia Hypoxia
Normoxia Normoxia Normoxia Hypoxia
4 hours hypoxia Normoxia Normoxia Normoxia
4 hours hypoxia Hypoxia Hypoxia Hypoxia
5 days hypoxia Normoxia Normoxia Normoxia
5 days hypoxia Hypoxia Hypoxia Hypoxia
\